Advertisement
Canada markets closed
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7263
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    82.58
    -0.15 (-0.18%)
     
  • Bitcoin CAD

    87,413.08
    +2,975.03 (+3.52%)
     
  • CMC Crypto 200

    1,311.21
    +425.67 (+48.06%)
     
  • GOLD FUTURES

    2,395.60
    -2.40 (-0.10%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • NASDAQ futures

    17,513.25
    -34.00 (-0.19%)
     
  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • CAD/EUR

    0.6821
    0.0000 (0.00%)
     

Stocks in play: RepliCel Life Sciences Inc.

Has recently received notifications of several patents issued, allowed, and granted to the Company from Europe, China, Hong Kong, Japan, the United States and South Africa. These relate to three of the distinct patent families RepliCel continues to prosecute around the world. RepliCel Life Sciences Inc. shares V.RP are trading up $0.025 at $0.33.